Literature DB >> 15242399

The bounty of RAGs: recombination signal complexes and reaction outcomes.

Patrick C Swanson1.   

Abstract

V(D)J recombination is a form of site-specific DNA rearrangement through which antigen receptor genes are assembled. This process involves the breakage and reunion of DNA mediated by two lymphoid cell-specific proteins, recombination activating genes RAG-1 and RAG-2, and ubiquitously expressed architectural DNA-binding proteins and DNA-repair factors. Here I review the progress toward understanding the composition, assembly, organization, and activity of the protein-DNA complexes that support the initiation of V(D)J recombination, as well as the molecular basis for the sequence-specific recognition of recombination signal sequences (RSSs) that are the targets of the RAG proteins. Parallels are drawn between V(D)J recombination and Tn5/Tn10 transposition with respect to the reactions, the proteins, and the protein-DNA complexes involved in these processes. I also consider the relative roles of the different sequence elements within the RSS in recognition, cleavage, and post-cleavage events. Finally, I discuss alternative DNA transactions mediated by the V(D)J recombinase, the protein-DNA complexes that support them, and factors and forces that control them.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15242399     DOI: 10.1111/j.0105-2896.2004.00159.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  52 in total

1.  Mechanistic basis for RAG discrimination between recombination sites and the off-target sites of human lymphomas.

Authors:  Noriko Shimazaki; Amjad Askary; Patrick C Swanson; Michael R Lieber
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

2.  Autoinhibition of DNA cleavage mediated by RAG1 and RAG2 is overcome by an epigenetic signal in V(D)J recombination.

Authors:  Gabrielle J Grundy; Wei Yang; Martin Gellert
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-13       Impact factor: 11.205

3.  Mechanism of fragility at BCL2 gene minor breakpoint cluster region during t(14;18) chromosomal translocation.

Authors:  Mridula Nambiar; Sathees C Raghavan
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

4.  RAG1 targeting in the genome is dominated by chromatin interactions mediated by the non-core regions of RAG1 and RAG2.

Authors:  Yaakov Maman; Grace Teng; Rashu Seth; Steven H Kleinstein; David G Schatz
Journal:  Nucleic Acids Res       Date:  2016-07-19       Impact factor: 16.971

5.  Double-strand break formation by the RAG complex at the bcl-2 major breakpoint region and at other non-B DNA structures in vitro.

Authors:  Sathees C Raghavan; Patrick C Swanson; Yunmei Ma; Michael R Lieber
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

6.  Both high mobility group (HMG)-boxes and the acidic tail of HMGB1 regulate recombination-activating gene (RAG)-mediated recombination signal synapsis and cleavage in vitro.

Authors:  Serge Bergeron; Tina Madathiparambil; Patrick C Swanson
Journal:  J Biol Chem       Date:  2005-07-01       Impact factor: 5.157

7.  Dynamics of synaptic SfiI-DNA complex: single-molecule fluorescence analysis.

Authors:  Mikhail A Karymov; Alexey V Krasnoslobodtsev; Yuri L Lyubchenko
Journal:  Biophys J       Date:  2007-02-02       Impact factor: 4.033

8.  A non-sequence-specific DNA binding mode of RAG1 is inhibited by RAG2.

Authors:  Shuying Zhao; Lori M Gwyn; Pallabi De; Karla K Rodgers
Journal:  J Mol Biol       Date:  2009-02-20       Impact factor: 5.469

Review 9.  Evolution of adaptive immunity from transposable elements combined with innate immune systems.

Authors:  Eugene V Koonin; Mart Krupovic
Journal:  Nat Rev Genet       Date:  2014-12-09       Impact factor: 53.242

10.  Fluorescence resonance energy transfer analysis of recombination signal sequence configuration in the RAG1/2 synaptic complex.

Authors:  Mihai Ciubotaru; Aleksei N Kriatchko; Patrick C Swanson; Frank V Bright; David G Schatz
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.